BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 6238585)

  • 41. Acute effects of fenoterol (Berotec) and ipratropium bromide (Atrovent) alone and in combination on bronchial hyperresponsiveness in asthmatic subjects.
    Salome CM; Wright W; Sedgwick CJ; Woolcock AJ
    Prog Clin Biol Res; 1988; 263():405-19. PubMed ID: 2967977
    [No Abstract]   [Full Text] [Related]  

  • 42. [Combination of anticholinergic, beta-2-sympathomimetic agents and theophylline in the treatment of chronic obstructive lung disease. A double-blind multicenter study of 60 patients].
    Bezel R; Brändli O; Braun P; Haegi V; Helcl J; Villiger B
    Schweiz Rundsch Med Prax; 1987 May; 76(22):632-6. PubMed ID: 2956661
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effect of Atrovent (ipratropium bromide) on the mechanics of respiration in patients with chronic obstructive pulmonary disease].
    Malinowski R; Frank-Piskorska A; Wasek Z; Koczorowski T
    Pneumonol Pol; 1986 Mar; 54(3):91-5. PubMed ID: 2942842
    [No Abstract]   [Full Text] [Related]  

  • 44. [Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(3-4):395-408. PubMed ID: 4282560
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bronchial obstruction--therapy with ipratropium bromide. Results of a multicenter clinical study].
    Stauder J; Flasch CI
    Fortschr Med; 1988 Oct; 106(31):631-4. PubMed ID: 2972596
    [No Abstract]   [Full Text] [Related]  

  • 46. The effect of ipratropium and fenoterol on methacholine-histamine-induced bronchoconstriction.
    Bandouvakis J; Cartier A; Roberts R; Ryan G; Hargreave FE
    Br J Dis Chest; 1981 Jul; 75(3):295-305. PubMed ID: 6457620
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative study of a vagolytic and a beta 2 sympathomimetic drug on the respiratory function of the asthmatic patient].
    Ramonatxo M; Prefaut C; Tronc JF; Michel FB; Chardon G
    Poumon Coeur; 1978; 34(2):95-9. PubMed ID: 149968
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Fenoterol in the treatment of bronchial obstruction in chronic asthmatiform bronchitis].
    Montanari S; Pasqua F; Gramiccioni E
    Clin Ter; 1982 Jul; 102(2):131-8. PubMed ID: 6216039
    [No Abstract]   [Full Text] [Related]  

  • 49. Bronchodilating and density dependence effects of fenoterol, ipratropium bromide and Duovent in reversible chronic obstructive pulmonary disease.
    Dubois PE; Delwiche JP; Minette P; Lulling J; Prignot J
    Respiration; 1986; 50 Suppl 2():280-4. PubMed ID: 2951822
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Blo-Bag, a disposable spacer.
    Woodcock A; Humberstone A; Kendall J; Pierce A
    Postgrad Med J; 1984; 60 Suppl 1():37-9. PubMed ID: 6233550
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination bronchodilator therapy in asthma.
    Ruffin RE; McIntyre E; Crockett AJ; Zielonka K; Alpers JH
    J Allergy Clin Immunol; 1982 Jan; 69(1 Pt 1):60-5. PubMed ID: 6459357
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison between a combination of ipratropium bromide plus fenoterol in a single metered dose inhaler (Duovent) and salbutamol in asthma.
    Flint KC; Hockley B; Johnson NM
    Postgrad Med J; 1983 Nov; 59(697):724-5. PubMed ID: 6227877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nebulised bronchodilator therapy in acute severe asthma.
    Town GI; O'Donnell TV
    N Z Med J; 1987 Jul; 100(828):466-7. PubMed ID: 2967449
    [No Abstract]   [Full Text] [Related]  

  • 54. Comparison of fenoterol, ipratropium bromide and their combination in patients with bronchial asthma.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1988; 30(2):98-102. PubMed ID: 2976027
    [No Abstract]   [Full Text] [Related]  

  • 55. [The oral application of berotec in the therapy of obstructive airway diseases].
    Veres R
    Fortschr Med; 1978 Mar; 96(10):553-7. PubMed ID: 631690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the intensity and duration of the bronchodilatory action of fenoterol-ipratropium bromide in combination compared with terbutaline and placebo in patients with chronic obstructive lung disease.
    Longhini E; Bozzoni M; Mastropasqua B; Marazzini L
    Respiration; 1986; 50 Suppl 2():169-72. PubMed ID: 2951799
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxitropium bromide, ipratropium bromide and fenoterol in exercise-induced asthma.
    Larsson K
    Respiration; 1982; 43(1):57-63. PubMed ID: 6211753
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison between fenoterol/ipratropium bromide combinations and salbutamol administered as nebulizer solution assessing dose-response and duration of action.
    McIntosh D
    Respiration; 1986; 50 Suppl 2():310-2. PubMed ID: 2951827
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ipratropium bromide and fenoterol by aerosolized solution.
    Jenkins CR; Chow CM; Fisher BL; Marlin GE
    Br J Clin Pharmacol; 1982 Jul; 14(1):113-5. PubMed ID: 6213250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical pharmacological trials of a new metered dose inhaler, IK-6, a combination of the bronchodilators fenoterol and ipratropium bromide (author's transl)].
    Kaik G; Kaik B; Laggner A
    Wien Med Wochenschr; 1980 Jun; 130(11):385-93. PubMed ID: 6449783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.